Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hut 8 Corp (HUT) vs Moderna, Inc. (MRNA) Price & Performance

Hut 8 CorpTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Hut 8 Corp vs Moderna, Inc. — how do they compare? Hut 8 Corp trades at $109.2 (market cap $11.36B), while Moderna, Inc. trades at $59.66 (market cap $23.60B). The key difference: Moderna, Inc. is far larger — about 2.1× Hut 8 Corp's market cap, and Hut 8 Corp is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.

HUTMRNA
Market Cap
$11.36B$23.60B
Sector
TechnologyHealth
52-Week High
$133.02$81.80
52-Week Low
$19.45$22.36
Enterprise Value
$11.63B$19.70B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hut 8 Corp

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $59.66, down 3.49% in the last session amid broader biotech volatility. The stock shows a mixed technical picture with bullish overall signals but bearish moving averages. Fundamentally, revenue has declined from pandemic peaks to $1.92B in 2025, with net losses widening to -$2.82B. Recent positive developments include an EU RSV vaccine contract and progress in cancer immunotherapy trials, with Q2 2026 earnings due July 31.

Outlook remains speculative as Moderna transitions beyond COVID-19 vaccines. Opportunities lie in its expanding pipeline in oncology and flu vaccines, but risks include sustained losses, competitive pressure, and execution hurdles. Analyst consensus is cautious with a $49 price target below current levels, reflecting uncertainty over profitability timeline.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hut 8 Corp

Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.

Read more on HUT

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA